Annex 1 Ready: Rommelag BFS in Thailand

Article by: Melchers Thailand Team

Annex 1 Ready: Rommelag BFS in Thailand

Is Your Sterile Manufacturing in Thailand Ready for Annex 1? 

The new EU GMP Annex 1 has redefined the standards for sterile pharmaceutical production. It’s no longer just about meeting requirements — it’s about how effectively you can control contamination, reduce human intervention, and ensure true aseptic integrity across your entire process. 

For pharmaceutical manufacturers in Thailand targeting: 

  • EU export markets
  • ASEAN regulatory harmonization  
  • High-value sterile injectables and ophthalmics  

Annex 1 compliance is becoming a key competitive advantage. 

The Challenge: Raising the Standard 

The updated Annex 1 places strong emphasis on: ntly reduces wear — even in extreme operating conditions. 

  • A comprehensive Contamination Control Strategy (CCS)
  • Minimizing human involvement in critical zones  
  • Ensuring consistent aseptic process performance

For many facilities, this raises an important question, are current production systems truly designed for this level of control? 

The Solution: Rommelag BFS Technology

Rommelag Blow-Fill-Seal (BFS) technology offers a smarter and more reliable way to align with Annex 1 expectations: 

  • A fully closed system for aseptic forming, filling, and sealing
  • Significantly reduced operator intervention
  • Built-in contamination control by design
  • Proven validation support for regulated global markets
Blow-Fill-Seal (BFS) plastic ampoules and bottles in various sizes used for sterile pharmaceutical packaging
Blow-Fill-Seal (BFS) plastic ampoules and bottles
Rommelag Blow-Fill-Seal (BFS) machine for aseptic forming, filling, and sealing in sterile pharmaceutical manufacturing
Rommelag Blow-Fill-Seal (BFS) machine

Beyond Compliance: What It Means for Your Business 

For decision-makers, this isn’t just about equipment — it’s about business impact: 

  • Lower risk of batch rejection 
  • Stronger brand protection
  • Greater audit confidence
  • Long-term readiness for global expansion

A Strategic Moment for Thailand

As Thailand continues to strengthen its role in ASEAN pharmaceutical manufacturing, companies are at a turning point. 

Will your sterile production system keep up with future regulatory demands — or require costly upgrades later? If you are planning to expand your sterile manufacturing capacity in Thailand, now is the time to evaluate your strategy. 

Rommelag BFS technology can be a key differentiator — enabling regulatory compliance, improving operational efficiency, and strengthening your global competitiveness. 

(for a better flow) Contact Melchers Thailand to learn how Rommelag BFS can support your production in becoming compliant, efficient and future-ready. 

Source: Rommelag 

27 Mar 2026

BLOG ARCHIVE